Project Description

Faraday
Helping Heart Attack Victims Recover Quicker And Better

Date & Time:

May 25, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval

About the Event:

Every forty seconds an American has a heart attack. While some may suffer damage from the attack itself, often lasting and more chronic damage is caused by a reperfusion injury which occurs when the heart is restarted.

Faraday Pharma has developed a drug that limits the effect of reperfusion. In a recently completed Phase 2 clinical study, FDY 5301 minimized reperfusion injury, greatly speeding recovery, and improving the patients’ quality of life after a heart attack.

Join our Fireside Chat on May 25 to hear from:

  • Dr. Stephen Hill, co-founder and CEO
  • Dr. Mark Roth, 2007 MacArthur Fellow and company co-founder
  • Dr. Steven Gillis, Faraday board chair and managing partner at ARCH Venture Partners

You’ll learn more about FDY 5301 and the potential it has to improve countless lives in the treatment of heart attacks.

Share this Event

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.